Skip to main content

Advertisement

SpringerLink
Log in

Genetic insights into cardiac tumors: a comprehensive review

  • Review Article
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Cardiac neoplasms are rare, however, also a curable form of the disease once detected early. In recent years the viscus tumors have gained their highlights, due to the advancement in techniques like echocardiography both 2D and 3D, MRI, etc. These cardiac tumors are divided based on their benign and malignant nature and also as well as primary and secondary cardiac tumors. Largely the primary cardiac tumors are often than secondary cardiac tumors. The secondary tumor happens anywhere in the body involving the heart. The most common malignant tumors are sarcoma, some are angiosarcomas, fibromas, rhabdosarcoma, and leiomyosarcoma. The primary sarcoma affects both men and women at an equal rate with non-specific symptoms. These conditions led to high demand in genomic testing that helps in spot the mutation that leads to the particular type of cardiac neoplasm and it additionally helps to screen the mutated sequence and stop it from being inherited. Recent studies on cardiac tumors have revealed many genes that are involved in tumorigenesis and technologies have enabled the right screening of the tumor location within the heart and their histopathological studies were also studied. This review principally focuses on the understanding of the various forms of cardiac tumors, genetic variants involved and their influence, genetic testing, and different diagnostic approaches in cardiac tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Yu K, Liu Y, Wang H, Hu S, Long C. Epidemiological and pathological characteristics of cardiac tumors: a clinical study of 242 cases. Interact Cardiovasc Thorac Surg. 2007;6:636–9.

    Article  PubMed  Google Scholar 

  2. Poterucha TJ, Kochav J, O’Connor DS, Rosner GF. Cardiac tumors: clinical presentation, diagnosis, and management. Curr Treat Options Oncol. 2019;20:1–15.

    Article  Google Scholar 

  3. Soiza RL, Donaldson AIC, Myint PK. Vaccine against arteriosclerosis: an update. Ther Adv Vaccines. 2018;9:259–61.

    Google Scholar 

  4. Bakhshi TJ, Georgel PT. Genetic and epigenetic determinants of diffuse large B-cell lymphoma. Blood Cancer J [Internet]. https://doi.org/10.1038/s41408-020-00389-w

  5. Palaskas N, Thompson K, Gladish G, Agha AM, Hassan S, Iliescu C, et al. Evaluation and management of cardiac tumors. Curr Treat Options Cardiovasc Med 2018;20.

  6. Mendes IC, Araújo AR, Anjos R, Teixeira A. Fetal giant cardiac tumor. Rev Port Cardiol. 2017;36:673–4. https://doi.org/10.1016/j.repc.2016.09.022.

    Article  PubMed  Google Scholar 

  7. O’Mahony D, Peikarz RL, Bandettini WP, Arai AE, Wilson WH, Bates SE. Cardiac involvement with lymphoma: a review of the literature. Clin Lymphoma Myeloma. 2008;8:249–52.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Leja MJ, Shah DJ, Reardon MJ. Primary cardiac tumors. Texas Hear Inst J. 2011;38:261–2.

    Google Scholar 

  9. Maraj S, Pressman GS, Figueredo VM. Primary cardiac tumors. Int J Cardiol. 2009;133:152–6. https://doi.org/10.1016/j.ijcard.2008.11.103.

    Article  PubMed  Google Scholar 

  10. Riberi A, Gariboldi V, Grisoli D, Collart F. Les tumeurs cardiaques. Rev Pneumol Clin [Internet]. 2010;66:95–103. https://doi.org/10.1016/j.pneumo.2009.12.012.

    Article  CAS  PubMed  Google Scholar 

  11. Topol EJ, Biern RO, Reitz BA. Cardiac papillary fibroelastoma and stroke. Echocardiographic diagnosis and guide to excision. Am J Med. 1986;80:129–32.

    Article  CAS  PubMed  Google Scholar 

  12. Darvishian F, Farmer P. Papillary fibroelastoma of the heart: report of two cases and review of the literature. Ann Clin Lab Sci. 2001;31:291–6.

    CAS  PubMed  Google Scholar 

  13. Grebenc ML, De Christenson MLR, Burke AP, Green CE, Galvin JR. Primary cardiac and pericardial neoplasms: radiologic-pathologic correlation. Radiographics. 2000;20:1073–103.

    Article  CAS  PubMed  Google Scholar 

  14. Vaideeswar P, Gupta R, Mishra P, Lanjewar C, Raut A. Atypical cardiac myxomas: a clinicopathologic analysis and their comparison to 64 typical myxomas. Cardiovasc Pathol [Internet]. 2012;21:180–7. https://doi.org/10.1016/j.carpath.2011.07.001.

    Article  PubMed  Google Scholar 

  15. Das BB, Sharma J. Cardiac rhabdomyoma and tuberous sclerosis: prenatal diagnosis and follow-up. Indian J Pediatr. 2003;70:87–9.

    Article  PubMed  Google Scholar 

  16. Chu ZG, Zhu ZY, Liu MQ, Lv FJ. Cardiac fibromas in the adult. J Card Surg. 2014;29:159–62.

    Article  PubMed  Google Scholar 

  17. Vaughan CJ, Veugelers M, Basson CT. Tumors and the heart: molecular genetic advances. Curr Opin Cardiol. 2001;16:195–200.

    Article  CAS  PubMed  Google Scholar 

  18. Bois MC, Bois JP, Anavekar NS, Oliveira AM, Maleszewski JJ. Benign lipomatous masses of the heart: a comprehensive series of 47 cases with cytogenetic evaluation. Hum Pathol [Internet]. 2014;45:1859–65. https://doi.org/10.1016/j.humpath.2014.05.003.

    Article  PubMed  Google Scholar 

  19. Hoffmeier A, Sindermann JR, Scheld HH, Martens S. Herztumoren - Diagnostik und chirurgische therapie. Dtsch Arztebl Int. 2014;111:205–11.

    PubMed  PubMed Central  Google Scholar 

  20. Brose MS, Volpe P, Feldman M, Kumar M, Rishi I, Gerrero R, et al. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res. 2002;62:6997–7000.

    CAS  PubMed  Google Scholar 

  21. Fatima J, Duncan AA, Maleszewski JJ, Kalra M, Oderich GS, Gloviczki P, et al. Primary angiosarcoma of the aorta, great vessels, and the heart. J Vasc Surg [Internet]. 2013;57:756–64. https://doi.org/10.1016/j.jvs.2012.09.023.

    Article  PubMed  Google Scholar 

  22. Gaballah AH, Jensen CT, Palmquist S, Pickhardt PJ, Duran A, Broering G, et al. Angiosarcoma: clinical and imaging features from head to toe. Br J Radiol. 2017;90.

  23. Uchida T, Kuroda Y, Sadahiro M. Primary biatrial cardiac rhabdomyosarcoma. Braz J Cardiovasc Surg. 2020;35:399–401.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Vujin B, Benc D, Srdic S, Bikicki M, Vuckovic D, Dodic S. Rhabdomyosarcoma of the heart. Herz. 2006;31:798–800.

    Article  PubMed  Google Scholar 

  25. Lee KA, Won HS, Shim JY, Lee PR, Kim A. Molecular genetic, cardiac and neurodevelopmental findings in cases of prenatally diagnosed rhabdomyoma associated with tuberous sclerosis complex. Ultrasound Obstet Gynecol. 2013;41:306–11.

    Article  CAS  PubMed  Google Scholar 

  26. Pluym ID, Sklansky M, Wu JY, Afshar Y, Holliman K, Devore GR, et al. Fetal cardiac rhabdomyomas treated with maternal sirolimus. Prenat Diagn. 2020;40:358–64.

    Article  CAS  PubMed  Google Scholar 

  27. Sarjeant JM, Butany J, Cusimano RJ. Cancer of the heart: epidemiology and management of primary tumors and metastases. Am J Cardiovasc Drugs. 2003;3:407–21.

    Article  PubMed  Google Scholar 

  28. Lamblin N, Bauters C, Hermant X, Lablanche JM, Helbecque N, Amouyel P. Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease. J Am Coll Cardiol [Internet]. 2002;40:43–8. https://doi.org/10.1016/S0735-1097(02)01909-5.

    Article  CAS  PubMed  Google Scholar 

  29. Elbardissi AW, Dearani JA, Daly RC, Mullany CJ, Orszulak TA, Puga FJ, et al. Survival after resection of primary cardiac tumors: a 48-year experience. Circulation. 2008;118.

  30. Singhal P, Luk A, Rao V, Butany J. Molecular basis of cardiac myxomas. Int J Mol Sci. 2014;15:1315–37.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Shern JF, Chen L, Chmielecki J, Wei JS, Patidar R, Rosenberg M, et al. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. Cancer Discov. 2014;4:216–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Kojima S, Sumiyoshi M, Watanabe Y, Suwa S, Matsumoto M, Nakata Y, et al. A Japanese case of familial cardiac myxoma associated with a mutation of the PRKAR1α gene. Intern Med. 2005;44:607–10.

    Article  CAS  PubMed  Google Scholar 

  33. Roque A, Kimbrough T, Traner C, Baehring JM, Huttner A, Adams J, et al. Somatic PRKAR1A mutation in sporadic atrial myxoma with cerebral parenchymal metastases: a case report. J Med Case Rep. 2019;13:1–9.

    Article  Google Scholar 

  34. Orlandi A, Ferlosio A, Roselli M, Chiariello L, Spagnoli LG. Cardiac sarcomas: an update. J Thorac Oncol. 2010;5:1483–9. https://doi.org/10.1097/JTO.0b013e3181e59a91.

    Article  PubMed  Google Scholar 

  35. Ferretti G, Curigliano G, Pastorino U, Cittadini A, Flamini G, Calabrò MG, et al. Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer. Clin Cancer Res. 2000;6:2393–400.

    CAS  PubMed  Google Scholar 

  36. Cooley D. Cardiac tumor Methodist Debakey. Cardiovasc J. 2010;6:1.

    Google Scholar 

  37. NRiggi, LCironi M-LS and IS. Immune activation and inflammation in HIV-1 infection. 2008;231–41.

  38. Kunze K, Spieker T, Gamerdinger U, Nau K, Berger J, Dreyer T, et al. A recurrent activating PLCG1 mutation in cardiac angiosarcomas increases apoptosis resistance and invasiveness of endothelial cells. Cancer Res. 2014;74:6173–83.

    Article  CAS  PubMed  Google Scholar 

  39. Manner J, Radlwimmer B, Hohenberger P, Mössinger K, Küffer S, Sauer C, et al. MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema. Am J Pathol. 2010;176:34–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Gonzalo G, Varela I, Mart N, Cristina P, Dom O, Gran O, et al. Regular Article. 2014;123:2034–43.

    Google Scholar 

  41. Leduc C, Jenkins SM, Sukov WR, Rustin JG, Maleszewski JJ. Cardiac angiosarcoma: histopathologic, immunohistochemical, and cytogenetic analysis of 10 cases. Hum Pathol [Internet]. 2017;60:199–207. https://doi.org/10.1016/j.humpath.2016.10.014.

    Article  CAS  PubMed  Google Scholar 

  42. Antonescu CR, Yoshida A, Guo T, Chang NE, Zhang L, Agaram NP, et al. KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors. Cancer Res. 2009;69:7175–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Gams P, Dolenc StraŽar Z, Šoštarič M, Bošnjak M, Kšela J. Cardiac melanoma metastasis with ERBB2 gene amplification: a potential for future targeted therapy. Case Rep Oncol. 2021;14:622–7.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Djerf EA, Trinks C, Abdiu A, Thunell LK, Hallbeck AL, Walz TM. ErbB receptor tyrosine kinases contribute to proliferation of malignant melanoma cells: Inhibition by gefitinib (ZD1839). Melanoma Res. 2009;19:156–66.

    Article  CAS  PubMed  Google Scholar 

  45. Capparelli C, Rosenbaum S, Berman-Booty LD, Salhi A, Gaborit N, Zhan T, et al. ErbB3-ErbB2 complexes as a therapeutic target in a subset of wild-type BRAF/NRAS cutaneous melanomas. Cancer Res. 2015;75:3554–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Shing DC, Mcmullan DJ, Roberts P, Smith K, Chin S, Nicholson J, et al. FUS/ERG gene fusions in Ewing’s tumors FUS/ERG gene fusions in Ewing’s tumors. 2003;4568–456.

  47. Szuhai K, Ijszenga M, De Jong D, Karseladze A, Tanke HJ, Hogendoorn PCW. The NFATc2 Gene is involved in a novel cloned translocation in a ewing sarcoma variant that couples its function in immunology to oncology. Clin Cancer Res. 2009;15:2259–68.

    Article  CAS  PubMed  Google Scholar 

  48. Peter M, Couturier J, Pacquement H, Michon J, Thomas G, Magdelenat H, et al. A new member of the ETS family fused to EWS in Ewing tumors. Oncogene. 1997;14:1159–64.

    Article  CAS  PubMed  Google Scholar 

  49. van der Ent W, Sand LGL, Hogendoorn PCW. Molecular genetics of Ewing sarcoma, model systems and finding novel (immuno-) therapeutic targets. J Transl Genet Genomics. 2018

  50. Ng TL, O’Sullivan MJ, Pallen CJ, Hayes M, Clarkson PW, Winstanley M, et al. Ewing sarcoma with novel translocation t(2;16) producing an in-flame fusion of FUS and FEV. J Mol Diagnostics. 2007;9:459–63.

    Article  Google Scholar 

  51. Dell’Amore A, Albertini A, Lamarra M. Twenty years experience in oncologic surgery for primary cardiac tumors. G di Chir. 2013;34:106–11.

    Google Scholar 

  52. Reardon MJ, Malaisrie SC, Walkes JC, Vaporciyan AA, Rice DC, Smythe WR, et al. Cardiac autotransplantation for primary cardiac tumors. Ann Thorac Surg. 2006;82:645–50.

    Article  PubMed  Google Scholar 

  53. Kwiatkowska J, Wałdoch A, Meyer-Szary J, Potaz P, Grzybiak M. Cardiac tumors in children: a 20-year review of clinical presentation, diagnostics and treatment. Adv Clin Exp Med. 2017;26:319–26.

    Article  PubMed  Google Scholar 

  54. Ried M, Rupprecht L, Hirt S, Zausig Y, Grube M, Resch M, et al. Sequential therapy of primary cardiac lymphoma with cardiectomy, total artificial heart support, and cardiac transplantation. J Hear Lung Transpl. 2010;29:707–9. https://doi.org/10.1016/j.healun.2010.01.014.

    Article  Google Scholar 

  55. Überfuhr P, Meiser B, Fuchs A, Schulze C, Reichenspurner H, Falk M, et al. Heart transplantation: an approach to treating primary cardiac sarcoma? J Hear Lung Transpl. 2002;21:1135–9.

    Article  Google Scholar 

  56. Bussani R, Castrichini M, Restivo L, Fabris E, Porcari A, Ferro F, et al. Myocardial disease (A Abbate, And G Sinagra, Section Editors) cardiac tumors: diagnosis, prognosis, and treatment. Curr CardiolRep; 2020.

  57. Burazor I, Aviel-Ronen S, Imazio M, Goitein O, Perelman M, Shelestovich N, et al. Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment. BMC Cancer. 2018;18:1–9.

    Article  Google Scholar 

  58. Padalino MA, Vida VL, Boccuzzo G, Tonello M, Sarris GE, Berggren H, et al. Surgery for primary cardiac tumors in children early and late results in a multicenter european congenital heart surgeons association study. Circulation. 2012;126:22–30.

    Article  PubMed  Google Scholar 

  59. Kajihara N, Tanoue Y, Eto M, Tomita Y, Masuda M, Morita S. Surgical experience of cardiac tumors: early and late results. Surg Today. 2006;36:602–7.

    Article  PubMed  Google Scholar 

  60. Mkalaluh S, Szczechowicz M, Torabi S, Schmack B, Sabashnikov A, Dib B, et al. Surgical treatment of cardiac tumors: insights from an 18-year single-center analysis. Med Sci Monit. 2017;23:6201–9.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Barreiro M, Renilla A, Jimenez JM, Martin M, Al Musa T, Garcia L, et al. Primary cardiac tumors: 32 Years of experience from a Spanish tertiary surgical center. Cardiovasc Pathol. 2013;22:424–7. https://doi.org/10.1016/j.carpath.2013.04.006.

    Article  PubMed  Google Scholar 

  62. Cresti A, Chiavarelli M, Glauber M, Tanganelli P, Scalese M, Cesareo F, et al. Incidence rate of primary cardiac tumors: a 14-year population study. J Cardiovasc Med. 2016;17:37–43.

    Article  Google Scholar 

  63. Oliveira GH, Al-Kindi SG, Hoimes C, Park SJ. Characteristics and survival of malignant cardiac tumors a 40-year analysis of >500 patients. Circulation. 2015;132:2395–402.

    Article  PubMed  Google Scholar 

  64. Pacini D, Careddu L, Pantaleo A, Parolari A, Leone O, Daprati A, et al. Primary malignant tumors of the heart: outcomes of the surgical treatment. Asian Cardiovasc Thorac Ann. 2015;23:645–51.

    Article  PubMed  Google Scholar 

  65. Vähäkangas KH, Bennett WP, Castrén K, Welsh JA, Khan MA, Blömeke B, et al. p53 and K-ras mutations in lung cancers from former and never-smoking women. Cancer Res. 2001;61:4350–6.

    PubMed  Google Scholar 

  66. Wangari-Talbot J, Chen S. Genetics of melanoma. Front Genet. 2013;3:1–16.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Genetic Engineering, School of Bioengineering, College of Engineering and Technology, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur, Chennai, Tamil Nadu, 603203, India

    Sivaramasundaram Sankarasubramanian, Prathiksha Prabhakar & Manoj Kumar Narasimhan

Authors
  1. Sivaramasundaram Sankarasubramanian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prathiksha Prabhakar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Manoj Kumar Narasimhan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manoj Kumar Narasimhan.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to declare that are relevant to the content of this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sankarasubramanian, S., Prabhakar, P. & Narasimhan, M.K. Genetic insights into cardiac tumors: a comprehensive review. Med Oncol 39, 164 (2022). https://doi.org/10.1007/s12032-022-01761-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-022-01761-5

Keywords

Search

Navigation